temozolomide has been researched along with Cancer of Endocrine Gland in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Temozolomide is a well-tolerated oral chemotherapy in patients with malignant DET, including those who have already received treatment." | 1.35 | Temozolomide: a safe and effective treatment for malignant digestive endocrine tumors. ( Couvelard, A; Faivre, S; Hammel, P; Hentic, O; Larroque, B; Lévy, P; Maire, F; Raymond, E; Ruszniewski, P; Yapur, L; Zappa, M, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maire, F | 1 |
| Hammel, P | 1 |
| Faivre, S | 1 |
| Hentic, O | 1 |
| Yapur, L | 1 |
| Larroque, B | 1 |
| Couvelard, A | 1 |
| Zappa, M | 1 |
| Raymond, E | 1 |
| Lévy, P | 1 |
| Ruszniewski, P | 1 |
1 other study available for temozolomide and Cancer of Endocrine Gland
| Article | Year |
|---|---|
Temozolomide: a safe and effective treatment for malignant digestive endocrine tumors.
Topics: Aged; Analysis of Variance; Antineoplastic Agents, Alkylating; Carcinoid Tumor; Dacarbazine; Digesti | 2009 |